Vivek Ramaswamy is an American entrepreneur in the biotechnology sector. He is the founder and CEO of the pharmaceutical company Roivant Sciences. He is also the founder of Axovant Sciences, a clinical-stage pharmaceutical company focusing on treatments for dementia, and the founder of other subsidiaries including: Altavant, Aruvant, Axovant, Datavant, Dermavant, Enzyvant, Myovant, Urovant, Genevant, Immunovant, Metavant, and Respivant.